Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Science and Society
  • Published:

The dynamic evolution of rheumatology in Korea

Abstract

Rheumatology was first recognized as a distinct clinical specialty in Korea just 35 years ago. Young professors who were trained in rheumatology in the USA and afterwards returned to Korea contributed substantially to advances in rheumatology clinical practice, educational programmes and research activities. They also established the Korean Rheumatism Association, later renamed the Korean College of Rheumatology. These young rheumatologists had a major role not only in raising the level of clinical and scientific activities, but also in promoting academic exchanges around the Asia–Pacific region, the USA and Europe. Subsequently, Korea's rapid economic growth and high education level enabled rheumatology to advance rapidly. Today, continued efforts are required to raise the standard of clinical and basic research, to optimize clinical practice with regard to new biologic agents, to exploit personalized and targeted therapies for the rheumatic diseases, and to meet the medical demands of Korea's ageing society.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Rapid growth of rheumatology in Korea.
Figure 2: Increases in the number of Korean rheumatologists over time.

References

  1. Park, M. H., Juji, T. & Tokunaga, K. HLA ethnic study of Japanese and Koreans. In HLA 1991 (eds Tsuji, K. et al.) Vol 1. 674–676 (Oxford University Press, 1992).

    Google Scholar 

  2. Jeon, C. H. et al. Pulmonary hypertension associated with rheumatic diseases: baseline characteristics from the Korean registry. Int. J. Rheum. Dis. 15, e80–e89 (2012).

    PubMed  Google Scholar 

  3. Bang, D. S. et al. Epidemiologic and clinical survey of Behçet's disease in Korea: the first multicenter study. J. Korean Med. Sci. 16, 615–618 (2001).

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Kim, I. et al. The prevalence of knee osteoarthritis in elderly community residents in Korea. J. Korean. Med. Sci. 25, 293–298 (2010).

    PubMed  PubMed Central  Google Scholar 

  5. Lawrence, R. C. et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 58, 26–35 (2008).

    PubMed  PubMed Central  Google Scholar 

  6. Cho, H. J. et al. Gender and prevalence of knee osteoarthritis types in elderly Koreans. J. Arthroplasty 26, 994–999 (2011).

    PubMed  Google Scholar 

  7. Kim, H. A. et al. The epidemiology of total knee replacement in South Korea: national registry data. Rheumatology (Oxford) 47, 88–91 (2008).

    Google Scholar 

  8. Helmick, C. G. et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 58, 15–25 (2008).

    PubMed  Google Scholar 

  9. Sung, Y. K., Cho, S. K., Choi, C. B. & Bae, S. C. Prevalence and incidence of rheumatoid arthritis in South Korea. Rheumatol. Int. 33, 1525–1532 (2013).

    PubMed  Google Scholar 

  10. Sung, Y. K. et al. Korean Observational Study Network for Arthritis (KORONA): establishment of a prospective multicenter cohort for rheumatoid arthritis in South Korea. Semin. Arthritis Rheum. 41, 745–751 (2012).

    PubMed  Google Scholar 

  11. Park, Y. B. et al. Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum. 46, 1714–1719 (2002).

    PubMed  Google Scholar 

  12. Park, Y. B. et al. Lipid profiles in untreated patients with rheumatoid arthritis. J. Rheumatol. 26, 1701–1704 (1999).

    CAS  PubMed  Google Scholar 

  13. Dougados, M. et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann. Rheum. Dis. 73, 62–68 (2014).

    PubMed  Google Scholar 

  14. Kim, H. Y. et al. Predominance of HLA-DRB1*0405 in Korean patients with rheumatoid arthritis. Ann. Rheum. Dis. 54, 988–990 (1995).

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Lee, H. S. et al. Genetic risk factors for rheumatoid arthritis differ in Caucasian and Korean populations. Arthritis Rheum. 60, 364–371 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Kim, K. et al. High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci. Ann. Rheum. Dis. 74, e13 (2015).

    PubMed  Google Scholar 

  17. Ju, J. H. et al. Prevalence of systemic lupus erythematosus in South Korea: an administrative database study. J. Epidemiol. 24, 295–303 (2014).

    PubMed  PubMed Central  Google Scholar 

  18. Shim, J. S., Sung, Y. K., Joo, Y. B., Lee, H. S. & Bae, S. C. Prevalence and incidence of systemic lupus erythematosus in South Korea. Rheumatol. Int. 34, 909–917 (2014).

    PubMed  Google Scholar 

  19. Lee, H. S. et al. Ethnic specificity of lupus-associated loci identified in a genome-wide association study in Korean women. Ann. Rheum. Dis. 73, 1240–1245 (2014).

    CAS  PubMed  Google Scholar 

  20. Kim, K. et al. The HLA-DRβ1 amino acid positions 11-13-26 explain the majority of SLE–MHC associations. Nat. Commun. 5, 5902 (2014).

    CAS  PubMed  Google Scholar 

  21. Choi, B. Y., Yoon, M. J., Shin, K., Lee, Y. J. & Song, Y. W. Characteristics of pleural effusions in systemic lupus erythematosus: differential diagnosis of lupus pleuritis. Lupus 24, 321–326 (2015).

    CAS  PubMed  Google Scholar 

  22. Ju, J. H. et al. Lupus mesenteric vasculitis can cause acute abdominal pain in patients with SLE. Nat. Rev. Rheumatol. 5, 273–281 (2009).

    PubMed  Google Scholar 

  23. Park, E. J. et al. Pregnancy outcomes in patients with systemic lupus erythematosus: a retrospective review of 62 pregnancies at a single tertiary center in South Korea. Int. J. Rheum. Dis. 17, 887–897 (2014).

    PubMed  Google Scholar 

  24. Koh, J. H., Ko, H. S., Kwok, S. K., Ju, J. H. & Park, S. H. Hydroxychloroquine and pregnancy on lupus flares in Korean patients with systemic lupus erythematosus. Lupus 24, 210–217 (2015).

    CAS  PubMed  Google Scholar 

  25. Kang, K. Y. et al. The causes of death in Korean patients with systemic lupus erythematosus over 11 years. Lupus 20, 989–997 (2011).

    CAS  PubMed  Google Scholar 

  26. Kang, K. Y. et al. Impact of interleukin-21 in the pathogenesis of primary Sjögren's syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands. Arthritis Res. Ther. 13, R179 (2011).

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Kwok, S. K. et al. A pathogenetic role for IL-21 in primary Sjögren syndrome. Nat. Rev. Rheumatol. 11, 368–374 (2015).

    CAS  PubMed  Google Scholar 

  28. Zhou, X. et al. HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans. Arthritis Rheum. 60, 3807–3814 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Cho, K. S. et al. Adult onset Still's disease: clinical features and prognostic factors in Korea. J. Korean Rheum. Assoc. 5, 64–75 (1998).

    Google Scholar 

  30. Kim, T. J. & Kim, T. H. Clinical spectrum of ankylosing spondylitis in Korea. Joint Bone Spine 77, 235–240 (2010).

    PubMed  Google Scholar 

  31. Lee, J. H. et al. Higher prevalence of peripheral arthritis among ankylosing spondylitis patients. J. Korean Med. Sci. 17, 669–673 (2002).

    PubMed  PubMed Central  Google Scholar 

  32. Baek, H. J. et al. Juvenile onset ankylosing spondylitis (JAS) has less severe spinal disease course than adult onset ankylosing spondylitis (AAS): clinical comparison between JAS and AAS in Korea. J. Rheumatol. 29, 1780–1785 (2002).

    PubMed  Google Scholar 

  33. Roh, E. Y. et al. HLA-A, -B, -DR allele frequencies and haplotypic associations in Koreans defined by generic-level DNA typing. Korean J. Lab. Med. 23, 420–430 (2003).

    Google Scholar 

  34. Park, K. S., Kang, S. Y. & Lee, W. I. HLA-B27 subtypes in Korean patients with ankylosing spondylitis [Korean]. Korean J. Lab. Med. 28, 46–52 (2008).

    CAS  PubMed  Google Scholar 

  35. Bang, D. S., Oh, S. H., Lee, K. H., Lee, E. S. & Lee, S. N. Influence of sex on patients with Behçet's disease in Korea. J. Korean Med. Sci. 18, 231–235 (2003).

    PubMed  PubMed Central  Google Scholar 

  36. Lee, Y. J. et al. Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behçet's disease. Ann. Rheum. Dis. 72, 1510–1516 (2013).

    CAS  PubMed  Google Scholar 

  37. Ju, J. H. et al. Modulation of STAT-3 in rheumatoid synovial T cells suppresses TH17 differentiation and increases the proportion of TREG cells. Arthritis Rheum. 64, 3543–3552 (2012).

    CAS  PubMed  Google Scholar 

  38. Kim, D. Y., Choi, M. J., Cho, S., Kim, D. W. & Bang, D. Changing clinical expression of Behçet disease in Korea during three decades (1983–2012): chronological analysis of 3674 hospital-based patients. Br. J. Dermatol. 170, 458–461 (2014).

    CAS  PubMed  Google Scholar 

  39. Park, D. J. et al. Cost-effectiveness analysis of HLA-B5801 genotyping in the treatment of gout patients with chronic renal insufficiency in Korea. Arthritis Care Res. (Hoboken) 67, 280–287 (2015).

    Google Scholar 

  40. Kim, H. Y. et al. Enhanced T cell proliferative response to type II collagen and synthetic peptide CII255–274 in patients with rheumatoid arthritis. Arthritis Rheum. 42, 2085–2093 (1999).

    CAS  PubMed  Google Scholar 

  41. Kim, K. W. et al. Up-regulation of stromal cell-derived factor 1 (CXCL12) production in rheumatoid synovial fibroblasts through interactions with T lymphocytes: role of interleukin-17 and CD40L–CD40 interaction. Arthritis Rheum. 56, 1076–1086 (2007).

    CAS  PubMed  Google Scholar 

  42. Cho, M. L. et al. Effector function of type II collagen-stimulated T cells from rheumatoid arthritis patients: cross-talk between T cells and synovial fibroblasts. Arthritis Rheum. 50, 776–784 (2004).

    CAS  PubMed  Google Scholar 

  43. Min, D. J. et al. Augmented production of chemokines by the interaction of type II collagen-reactive T cells with rheumatoid synovial fibroblasts. Arthritis Rheum. 50, 1146–1155 (2004).

    CAS  PubMed  Google Scholar 

  44. Lee, J., Sim, J. H. & Kim, I. J. Peripheral immature B cells: modulators of autoimmunity. Int. J. Rheum. Dis. 18, 200–207 (2014).

    PubMed  Google Scholar 

  45. Park, S. H. et al. Shift toward T helper 1 cytokines by type II collagen-reactive T cells in patients with rheumatoid arthritis. Arthritis Rheum. 44, 561–569 (2001).

    CAS  PubMed  Google Scholar 

  46. Yoo, S. A. et al. A novel pathogenic role of the ER chaperone GRP78/BiP in rheumatoid arthritis. J. Exp. Med. 209, 871–886 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Yoon, H. J. et al. NF-AT5 is a critical regulator of inflammatory arthritis. Arthritis Rheum. 63, 1843–1852 (2011).

    CAS  PubMed  Google Scholar 

  48. Cho, M. L. et al. STAT3 and NF-κB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice. J. Immunol. 176, 5652–5661 (2006).

    CAS  PubMed  Google Scholar 

  49. Park, J. S. et al. p53 controls autoimmune arthritis via STAT-mediated regulation of the TH17 cell/TREG cell balance in mice. Arthritis Rheum. 65, 949–959 (2013).

    CAS  PubMed  Google Scholar 

  50. Min, S. Y. et al. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen. Arthritis Res. Ther. 6, R213–R219 (2004).

    CAS  PubMed  PubMed Central  Google Scholar 

  51. Kang, Y. M. et al. CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis. J. Exp. Med. 195, 1325–1336 (2002).

    CAS  PubMed  PubMed Central  Google Scholar 

  52. Kim, Y. G. et al. Effect of interleukin-32γ on differentiation of osteoclasts from CD14+ monocytes. Arthritis Rheum. 62, 515–523 (2010).

    CAS  PubMed  Google Scholar 

  53. Mun, S. H. et al. Interleukin-33 stimulates formation of functional osteoclasts from human CD14+ monocytes. Cell. Mol. Life Sci. 67, 3883–3892 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  54. Hwang, S. J. et al. Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis. Arthritis Res. Ther. 14, R14 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  55. Min, S. Y. et al. Antigen-induced, tolerogenic CD11c+, CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis. Arthritis Rheum. 54, 887–898 (2006).

    CAS  PubMed  Google Scholar 

  56. Park, M. J. et al. Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+ regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model. Arthritis Res. Ther. 10, R11 (2008).

    PubMed  PubMed Central  Google Scholar 

  57. Kwak, H. B. et al. Reciprocal cross-talk between RANKL and interferon-γ-inducible protein 10 is responsible for bone-erosive experimental arthritis. Arthritis Rheum. 58, 1332–1342 (2008).

    CAS  PubMed  Google Scholar 

  58. Lee, E. Y., Lee, Z. H. & Song, Y. W. CXCL10 and autoimmune diseases. Autoimmun. Rev. 8, 379–383 (2009).

    CAS  PubMed  Google Scholar 

  59. Kim, K. W. et al. Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts. Arthritis Rheum. 64, 1015–1023 (2012).

    CAS  PubMed  Google Scholar 

  60. Oh, J. et al. Progranulin and a five transmembrane domain-containing receptor-like gene are the key components in receptor activator of nuclear factor κB (RANK)-dependent formation of multinucleated osteoclasts. J. Biol. Chem. 290, 2042–2052 (2015).

    CAS  PubMed  Google Scholar 

  61. Ju, J. H. et al. IL-23 induces receptor activator of NF-κB ligand expression on CD4+ T cells and promotes osteoclastogenesis in an autoimmune arthritis model. J. Immunol. 181, 1507–1518 (2008).

    CAS  PubMed  Google Scholar 

  62. Kim, H. R. et al. Reciprocal activation of CD4+ T cells and synovial fibroblasts by stromal cell-derived factor 1 promotes RANKL expression and osteoclastogenesis in rheumatoid arthritis. Arthritis Rheumatol. 66, 538–548 (2014).

    CAS  PubMed  Google Scholar 

  63. Cho, Y. N. et al. Mucosal-associated invariant T cell deficiency in systemic lupus erythematosus. J. Immunol. 193, 3891–3901 (2014).

    CAS  PubMed  Google Scholar 

  64. Park, Y. W. et al. Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus. Arthritis Rheum. 60, 1753–1763 (2009).

    CAS  PubMed  Google Scholar 

  65. Lee, S. W. et al. Cilostazol protects rat chondrocytes against nitric oxide-induced apoptosis in vitro and prevents cartilage destruction in a rat model of osteoarthritis. Arthritis Rheum. 58, 790–800 (2008).

    CAS  PubMed  Google Scholar 

  66. Lee, S. W. et al. TRAIL induces apoptosis of chondrocytes and influences the pathogenesis of experimentally induced rat osteoarthritis. Arthritis Rheum. 50, 534–542 (2004).

    CAS  PubMed  Google Scholar 

  67. Liang, G., Ahlqvist, K., Pannem, R., Posern, G. & Massoumi, R. Serum response factor controls CYLD expression via MAPK signaling pathway. PLoS ONE 6, e19613 (2011).

    CAS  PubMed  PubMed Central  Google Scholar 

  68. Aigner, T. & Kim, H. A. Apoptosis and cellular vitality: issues in osteoarthritic cartilage degeneration. Arthritis Rheum. 46, 1986–1996 (2002).

    CAS  PubMed  Google Scholar 

  69. Kim, H. A. et al. The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes. Arthritis Rheum. 54, 2152–2163 (2006).

    CAS  PubMed  Google Scholar 

  70. Yoon, C. H. et al. Validity of the sonographic longitudinal sagittal image for assessment of the cartilage thickness in the knee osteoarthritis. Clin. Rheumatol. 27, 1507–1516 (2008).

    PubMed  Google Scholar 

  71. Lee, J., Kim, H.-R., Lee, S. H. & Kim, H.-Y. Epigenetic modification in systemic rheumatic diseases. J. Rheum. Dis. 20, 140–148 (2013).

    CAS  Google Scholar 

  72. You, S. et al. A systems approach to rheumatoid arthritis. PLoS ONE 7, e51508 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  73. Kang, Y. M. et al. LIGHT up-regulated on B lymphocytes and monocytes in rheumatoid arthritis mediates cellular adhesion and metalloproteinase production by synoviocytes. Arthritis Rheum. 56, 1106–1117 (2007).

    CAS  PubMed  Google Scholar 

  74. Nam, E. J. et al. A matrix metalloproteinase 1-cleavable composite peptide derived from transforming growth factor β-inducible gene H3 potently inhibits collagen-induced arthritis. Arthritis Rheum. 65, 1753–1763 (2013).

    CAS  PubMed  Google Scholar 

  75. Lee, J. et al. Generation of disease-specific induced pluripotent stem cells from patients with rheumatoid arthritis and osteoarthritis. Arthritis Res. Ther. 16, R41 (2014).

    PubMed  PubMed Central  Google Scholar 

  76. Navarra, S. V. et al. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet 377, 721–731 (2011).

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors acknowledge Professor Andrew. H. Kang (University of Tennessee, School of Medicine, Memphis, Tennessee, USA) not only for his tireless efforts in training and education in rheumatology for young Korean internists, but also for his tremendous support and promotion of international affairs, as well as encouragement of research activities, in the past 30 years. We also thank Drs C. S. Cho, D. H. Yoo, S. C. Bae, T. H. Kim, S. K. Lee, E. M. Koh, W. U. Kim, M. H. Park, S. H. Lee and H. R. Kim for their help with data acquisition and manuscript preparation. The opinions expressed in this article are solely those of the authors and do not reflect the views of KCR.

Author information

Authors and Affiliations

Authors

Contributions

Both authors contributed equally to all aspects of the preparation of this manuscript.

Corresponding authors

Correspondence to Ho-Youn Kim or Yeong-Wook Song.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, HY., Song, YW. The dynamic evolution of rheumatology in Korea. Nat Rev Rheumatol 12, 183–189 (2016). https://doi.org/10.1038/nrrheum.2015.165

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2015.165

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing